Abstract
Quantum dots (QDs) are new generation of fluorophores with superior optical properties. For biological applications of QDs, proper surface modification and further conjugation with biomolecules are necessary to make these nanocrystals biocompatible as well as target-recognizable. Preparation of QDs bioconjugates was reviewed in this paper to demonstrate general strategies in the bioconjugation of QDs and typical QDs bioconjugates including QDs conjugated with peptides, proteins or oligonucleotides were introduced. Recent examples on the applications of QDs bioconjugates for sensitive detection of biomolecules such as nucleic acids or proteins were reviewed. QDs bioconjugates used in cell labeling and trafficking, in detection of subcellular molecules and in imaging protein dynamics in live cells were also reviewed with an emphasis on current work reported in the past two years. Latest progress on the application of QDs bioconjugates for in vivo imaging was briefly covered and perspective on QDs bioconjugates and their applications in bioimaging was discussed with related to the issues to be addressed in future QDs applications.
Keywords: Quantum dots (QDs), molecular imaging, peptide, protein, oligonucleotide, fluorescence
Current Pharmaceutical Biotechnology
Title: Preparation of Quantum Dot Bioconjugates and their Applications in Bio-Imaging
Volume: 11 Issue: 6
Author(s): Jinbo Li, Dongdong Wu, Zhengrui Miao and Yan Zhang
Affiliation:
Keywords: Quantum dots (QDs), molecular imaging, peptide, protein, oligonucleotide, fluorescence
Abstract: Quantum dots (QDs) are new generation of fluorophores with superior optical properties. For biological applications of QDs, proper surface modification and further conjugation with biomolecules are necessary to make these nanocrystals biocompatible as well as target-recognizable. Preparation of QDs bioconjugates was reviewed in this paper to demonstrate general strategies in the bioconjugation of QDs and typical QDs bioconjugates including QDs conjugated with peptides, proteins or oligonucleotides were introduced. Recent examples on the applications of QDs bioconjugates for sensitive detection of biomolecules such as nucleic acids or proteins were reviewed. QDs bioconjugates used in cell labeling and trafficking, in detection of subcellular molecules and in imaging protein dynamics in live cells were also reviewed with an emphasis on current work reported in the past two years. Latest progress on the application of QDs bioconjugates for in vivo imaging was briefly covered and perspective on QDs bioconjugates and their applications in bioimaging was discussed with related to the issues to be addressed in future QDs applications.
Export Options
About this article
Cite this article as:
Li Jinbo, Wu Dongdong, Miao Zhengrui and Zhang Yan, Preparation of Quantum Dot Bioconjugates and their Applications in Bio-Imaging, Current Pharmaceutical Biotechnology 2010; 11 (6) . https://dx.doi.org/10.2174/138920110792246582
DOI https://dx.doi.org/10.2174/138920110792246582 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antisense Oligonucleotide Drug Design
Current Pharmaceutical Design Silybin and Silymarin - New and Emerging Applications in Medicine
Current Medicinal Chemistry Imaging of Integrins as Biomarkers for Tumor Angiogenesis
Current Pharmaceutical Design High-Dose Linoleic Acid Activated JAK2-STAT3 Signaling Pathway Involved in Cytokine Production and Lipogenesis in Pancreatic Exocrine Cells
Current Molecular Medicine Bladder Cancer and Stem Cells
Current Signal Transduction Therapy Psychological Factors Associated with Response to Treatment in Rheumatoid Arthritis
Current Pharmaceutical Design Harnessing the Capacity of Cell-Penetrating Peptides for Drug Delivery to the Central Nervous System
Current Pharmaceutical Biotechnology Synthesis and Stereochemistry-Activity Relationship of Chiral Thiourea Derivatives as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer
Current Pharmaceutical Design Isothiocyanates as Cancer Chemopreventive Agents: Their Biological Activities and Metabolism in Rodents and Humans
Current Drug Metabolism Biological Modulation by Lectins and Their Ligands in Tumor Progression and Metastasis
Anti-Cancer Agents in Medicinal Chemistry Vitamin D Analogs as Anti-Carcinogenic Agents
Anti-Cancer Agents in Medicinal Chemistry Pharmacological Properties of Indazole Derivatives: Recent Developments
Mini-Reviews in Medicinal Chemistry Targeting Metallothionein for Prognosis and Treatment of Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery Cell Penetrating Peptides and the Mechanisms for Intracellular Entry
Current Pharmaceutical Biotechnology The Therapeutic Potential of ADAM15
Current Pharmaceutical Design Targeting Opioid and Neurokinin-1 Receptors to Treat Alcoholism
Current Medicinal Chemistry Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Exosomes and Lung Cancer: Roles in Pathophysiology, Diagnosis and Therapeutic Applications
Current Medicinal Chemistry In Vitro and In Vivo Evaluation of [99mTc(CO)3]-Radiolabeled ErbB-2-Targeting Peptides for Breast Carcinoma Imaging
Current Radiopharmaceuticals